# Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)

> **NCT06195514** · — · NO_LONGER_AVAILABLE · sponsor: **Takeda**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** TAK-113

## Key facts

- **NCT ID:** NCT06195514
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06195514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06195514, "Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06195514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*